Havas Health & You introduces Havas ECS (Endocannabinoid Science), a strategic communications advisory and education company focused on the importance and value of foundational scientific knowledge of the endocannabinoid system, to better guide and better inform improved decision making on ECS-related topics.
Fueled by deep subject matter expertise, and a network of medical advisors skilled in the application of cannabinoid medicine, Havas ECS helps clients seeking a science-based approach to their communications needs.
Purisys has more than a decade of experience developing and manufacturing cannabinoids – starting with a commercial Drug Master File for Δ9-THC (dronabinol) API since 2007. Our personnel have a 40-plus year track record managing controlled substance APIs for pharmaceutical production in accordance with international rules and global regulations. We offer technical support in every phase of the drug development process, from preclinical studies through commercialization of a wide variety of dosage forms and formulations
As the first R&D cannabis company in Latin America, Entourage Phytolab has a strong branding and reputation in largest pharmaceutical market in the region, Brazil. It has developed a state-of-the art extraction and innovative formulations that will be used in its five drugs pipeline. Its first drug, a full spectrum CBD formulation for epilepsy with improved bioavailability, is scheduled to begin sales in Brazilian pharmacies in early 2021 and to get its full register in 2022.
KinetoChem LLC is a US-based company which manufactures high purity synthetic cannabinoids for all stages of research. We offer Active Pharmaceutical Ingredients (APIs) for pre-clinical, clinical, and consumer goods with various quantities available (milligram, gram, and kilogram). Our facility and manufacturing processes meet all state and federal regulatory requirements including DEA Schedule I licensing for Analysis, Bulk Manufacturing, and Export.